-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $120

Benzinga·08/20/2026 17:57:52
語音播報
Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Neutral and raises the price target from $67 to $120.